Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009;18:3044-8. [PMID: 19843670 DOI: 10.1158/1055-9965.epi-09-0306] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

For:	Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009;18:3044-8. [PMID: 19843670 DOI: 10.1158/1055-9965.epi-09-0306] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

Number

Cited by Other Article(s)

Chen H, Majumdar A, Wang L, Kar S, Brown KM, Feng H, Turman C, Dennis J, Easton D, Michailidou K, Simard J, Bishop T, Cheng IC, Huyghe JR, Schmit SL, O’Mara TA, Spurdle AB, Gharahkhani P, Schumacher J, Jankowski J, Gockel I, Bondy ML, Houlston RS, Jenkins RB, Melin B, Lesseur C, Ness AR, Diergaarde B, Olshan AF, Amos CI, Christiani DC, Landi MT, McKay JD, Brossard M, Iles MM, Law MH, MacGregor S, Beesley J, Jones MR, Tyrer J, Winham SJ, Klein AP, Petersen G, Li D, Wolpin BM, Eeles RA, Haiman CA, Kote-Jarai Z, Schumacher FR, Brennan P, Chanock SJ, Gaborieau V, Purdue MP, Pharoah P, Hung RJ, Amundadottir LT, Kraft P, Pasaniuc B, Lindström S. Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. HGG ADVANCES 2021;2:100041. [PMID: 34355204 PMCID: PMC8336922 DOI: 10.1016/j.xhgg.2021.100041] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Accepted: 06/04/2021] [Indexed: 12/23/2022] Open

Affiliation(s)

Hongjie Chen Department of Epidemiology, University of Washington, Seattle, WA, USA
Arunabha Majumdar Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India
Lu Wang Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA
Siddhartha Kar Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Kevin M. Brown Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Helian Feng Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Constance Turman Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Joe Dennis Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Douglas Easton Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Kyriaki Michailidou Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus
Jacques Simard Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada
Breast Cancer Association Consortium (BCAC) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Timothy Bishop Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK
Iona C. Cheng Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA
Jeroen R. Huyghe Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Stephanie L. Schmit Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA
Colorectal Transdisciplinary Study (CORECT) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Colon Cancer Family Registry Study (CCFR) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Tracy A. O’Mara Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Amanda B. Spurdle Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Endometrial Cancer Association Consortium (ECAC) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Puya Gharahkhani Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Johannes Schumacher Center for Human Genetics, University Hospital of Marburg, Marburg, Germany
Janusz Jankowski College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK
Ines Gockel Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany
Esophageal Cancer GWAS Consortium Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Melissa L. Bondy Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA
Richard S. Houlston Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
Robert B. Jenkins Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA
Beatrice Melin Department of Radiation Sciences, Umeå University, Umeå, Sweden
Glioma International Case Control Consortium (GICC) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Corina Lesseur Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France
Andy R. Ness National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK
Brenda Diergaarde Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA
Andrew F. Olshan Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
Head-Neck Cancer GWAS Consortium Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Christopher I. Amos Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA
David C. Christiani Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Maria T. Landi Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
James D. McKay International Agency for Research on Cancer, World Health Organization, Lyon, France
International Lung Cancer Consortium (ILCCO) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Myriam Brossard Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada
Mark M. Iles Leeds Institute for Data Analytics, University of Leeds, Leeds, UK
Matthew H. Law Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia
Stuart MacGregor Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Melanoma GWAS Consortium Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Jonathan Beesley Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Michelle R. Jones Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Jonathan Tyrer Department of Oncology, University of Cambridge, Cambridge, UK
Stacey J. Winham Department of Health Science Research, Mayo Clinic, Rochester, MN, USA
Ovarian Cancer Association Consortium (OCAC) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Alison P. Klein Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA
Gloria Petersen Department of Health Science Research, Mayo Clinic, Rochester, MN, USA
Donghui Li Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Brian M. Wolpin Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA
Pancreatic Cancer Case-Control Consortium (PANC4) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Pancreatic Cancer Cohort Consortium (PanScan) Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Rosalind A. Eeles Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK
Christopher A. Haiman Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA
Zsofia Kote-Jarai Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK
Fredrick R. Schumacher Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA
PRACTICAL consortium Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
CRUK Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
BPC3 Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
CAPS Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
PEGASUS Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Paul Brennan National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK
Stephen J. Chanock Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Valerie Gaborieau National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK
Mark P. Purdue Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Renal Cancer GWAS Consortium Department of Epidemiology, University of Washington, Seattle, WA, USA Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Mathematics, Indian Institute of Technology Hyderabad, Kandi, Telangana, India Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Medicine, Faculty of Medicine, Université Laval and Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia Center for Human Genetics, University Hospital of Marburg, Marburg, Germany College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE Comprehensive Clinical Trials Unit, University College London, London, UK Department of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA Department of Radiation Sciences, Umeå University, Umeå, Sweden Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA International Agency for Research on Cancer, World Health Organization, Lyon, France National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK Bristol Dental School, University of Bristol, Bristol, UK Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA UPMC Hillman Cancer Center, Pittsburgh, PA, USA Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA Genetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada Leeds Institute for Data Analytics, University of Leeds, Leeds, UK School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Oncology, University of Cambridge, Cambridge, UK Department of Health Science Research, Mayo Clinic, Rochester, MN, USA Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, USA Oncogenetics Team, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA Seidman Cancer Center, University Hospitals, Cleveland, OH, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Paul Pharoah Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Rayjean J. Hung Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada
Laufey T. Amundadottir Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Peter Kraft Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Bogdan Pasaniuc Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Sara Lindström Department of Epidemiology, University of Washington, Seattle, WA, USA Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Collapse

Zhao X, Li Y, Wu H. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Int J Mol Med 2018;42:1495-1507. [PMID: 29956722 PMCID: PMC6089755 DOI: 10.3892/ijmm.2018.3739] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2017] [Accepted: 05/14/2018] [Indexed: 12/19/2022] Open

Abstract

Acute myeloid leukemia (AML) is the most common type of acute leukemia and is a heterogeneous clonal disorder. At present, the pathogenesis of AML and potential methods to effectively prevent AML have become areas of interest in research. In the present study, two messenger ribonucleic acid sequencing datasets of patients with AML were downloaded from the Cancer Genome Atlas and Gene Expression Omnibus databases. The differentially expressed genes (DEGs) of the poor and good prognosis groups were screened using the Linear Models for Microarray Data package, and the prognosis-related genes were screened using univariate Cox regression analysis. A total of 206 significant DEGs were identified. Following univariate and multivariate Cox regression analysis, 14 genes significantly associated with prognosis were screened and six of these genes, including triggering receptor expressed on myeloid cells 2 (TREML2), cysteine-glutamate transporter (SLC7A11), NACHT, LRR, and PYD domains-containing protein 2 (NLRP2), DNA damage-inducible transcript 4 protein (DDIT4), lymphocyte‑specific protein 1 (LSP1) and C-type lectin domain family 11 member A (CLEC11A), were used to construct model equations for risk assessment. The prognostic scoring system was used to evaluate risk for each patient, and the results showed that patients in the low-risk group had a longer survival time, compared with those in the high-risk group (P=9.59e-06 for the training dataset and P=0.00543 for the validation dataset). A total of eight main Kyoto Encyclopedia of Genes and Genomes pathways were identified, the top three of which were hematopoietic cell lineage, focal adhesion, and regulation of actin cytoskeleton. Taken together, the results showed that the scoring system established in the present study was credible and that the six genes were identified, which were significantly associated with the risk assessment of AML, offer potential as prognostic biomarkers. These findings may provide clues for further clarifying the pathogenesis of AML.

Collapse

Zhang Y, Li W, Hong Y, Wu G, He K, Liu D. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk. J Genet 2018;96:283-289. [PMID: 28674227 DOI: 10.1007/s12041-017-0774-y] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Huo D. Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry. Cancer Epidemiol Biomarkers Prev 2017;27:116-118. [PMID: 29254938 DOI: 10.1158/1055-9965.epi-17-0755] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Revised: 11/09/2017] [Accepted: 11/13/2017] [Indexed: 12/20/2022] Open

Zhao XK, Mao YM, Meng H, Song X, Hu SJ, Lv S, Cheng R, Zhang TJ, Han XN, Ren JL, Qi YJ, Wang LD. Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China. PLoS One 2017;12:e0177504. [PMID: 28542283 PMCID: PMC5436667 DOI: 10.1371/journal.pone.0177504] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2016] [Accepted: 04/30/2017] [Indexed: 11/19/2022] Open

Abstract

Background

Cancers from lung and esophagus are the leading causes of cancer-related deaths in China and share many similarities in terms of histological type, risk factors and genetic variants. Recent genome-wide association studies (GWAS) in Chinese esophageal cancer patients have demonstrated six high-risk candidate single nucleotide polymorphisms (SNPs). Thus, the present study aimed to determine the risk of these SNPs predisposing to lung cancer in Chinese population.

Methods

A total of 1170 lung cancer patients and 1530 normal subjects were enrolled in this study from high-incidence areas for esophageal cancer in Henan, northern China. Five milliliters of blood were collected from all subjects for genotyping. Genotyping of 20 high-risk SNP loci identified from genome-wide association studies (GWAS) on esophageal, lung and gastric cancers was performed using TaqMan allelic discrimination assays. Polymorphisms were examined for deviation from Hardy-Weinberg equilibrium (HWE) using Х² test. Bonferroni correction was performed to correct the statistical significance of 20 SNPs with the risk of lung cancer. The Pearson’s Х² test was used to compare the distributions of gender, TNM stage, histopathological type, smoking and family history by lung susceptibility genotypes. Kaplan-Meier and Cox regression analyses were carried out to evaluate the associations between genetic variants and overall survival.

Results

Four of the 20 SNPs identified as high-risk SNPs in Chinese esophageal cancer showed increased risk for Chinese lung cancer, which included rs3769823 (OR = 1.26; 95% CI = 1.107–1.509; P = 0.02), rs10931936 (OR = 1.283; 95% CI = 1.100–1.495; P = 0.04), rs2244438 (OR = 1.294; 95% CI = 1.098–1.525; P = 0.04) and rs13016963 (OR = 1.268; 95% CI = 1.089–1.447; P = 0.04). All these SNPs were located at 2q33 region harboringgenes of CASP8, ALS2CR12 and TRAK2. However, none of these susceptibility SNPs was observed to be significantly associated with gender, TNM stage, histopathological type, smoking, family history and overall survival.

Conclusions

The present study identified four high-risk SNPs at 2q33 locus for Chinese lung cancer and demonstrated the shared susceptibility loci at 2q33 region for Chinese lung and esophageal cancers.

Collapse

Zhang H, Wang Y, Liu Z, Yao B, Dou C, Xu M, Li Q, Jia Y, Wu S, Tu K, Liu Q. Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS Open Bio 2016;6:1227-1237. [PMID: 28255535 PMCID: PMC5324767 DOI: 10.1002/2211-5463.12139] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Revised: 08/29/2016] [Accepted: 09/27/2016] [Indexed: 12/13/2022] Open

Ghadban T, Schmidt-Yang M, Uzunoglu FG, Perez DR, El Gammal AT, Miro JT, Wellner U, Pantel K, Izbicki JR, Vashist YK. Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer. Cancer Genet 2015;208:595-601. [PMID: 26598072 DOI: 10.1016/j.cancergen.2015.09.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2015] [Revised: 09/21/2015] [Accepted: 09/22/2015] [Indexed: 12/20/2022]

Bawa P, Zackaria S, Verma M, Gupta S, Srivatsan R, Chaudhary B, Srinivasan S. Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer. PLoS One 2015;10:e0122143. [PMID: 25933431 PMCID: PMC4416928 DOI: 10.1371/journal.pone.0122143] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2014] [Accepted: 02/10/2015] [Indexed: 02/03/2023] Open

Abstract

Recently, large numbers of normal human tissues have been profiled for non-coding RNAs and more than fourteen thousand long intergenic non-coding RNAs (lincRNAs) are found expressed in normal human tissues. The functional roles of these normal lincRNAs (nlincRNAs) in the regulation of protein coding genes in normal and disease biology are yet to be established. Here, we have profiled two RNA-seq datasets including cancer and matched non-neoplastic tissues from 12 individuals from diverse demography for both coding genes and nlincRNAs. We find 130 nlincRNAs significantly regulated in cancer, with 127 regulated in the same direction in the two datasets. Interestingly, according to Illumina Body Map, significant numbers of these nlincRNAs display baseline null expression in normal prostate tissues but are specific to other tissues such as thyroid, kidney, liver and testis. A number of the regulated nlincRNAs share loci with coding genes, which are either co-regulated or oppositely regulated in all cancer samples studied here. For example, in all cancer samples i) the nlincRNA, TCONS_00029157, and a neighboring tumor suppressor factor, SIK1, are both down regulated; ii) several thyroid-specific nlincRNAs in the neighborhood of the thyroid-specific gene TPO, are both up-regulated; and iii) the TCONS_00010581, an isoform of HEIH, is down-regulated while the neighboring EZH2 gene is up-regulated in cancer. Several nlincRNAs from a prostate cancer associated chromosomal locus, 8q24, are up-regulated in cancer along with other known prostate cancer associated genes including PCAT-1, PVT1, and PCAT-92. We observe that there is significant bias towards up-regulation of nlincRNAs with as high as 118 out of 127 up-regulated in cancer, even though regulation of coding genes is skewed towards down-regulation. Considering that all reported cancer associated lincRNAs (clincRNAs) are biased towards up-regulation, we conclude that this bias may be functionally relevant.

Collapse

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer. J Hum Genet 2014;59:661-6. [PMID: 25354935 DOI: 10.1038/jhg.2014.90] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2014] [Revised: 08/31/2014] [Accepted: 09/11/2014] [Indexed: 12/20/2022]

Mannion S, Mtintsilana A, Posthumus M, van der Merwe W, Hobbs H, Collins M, September AV. Genes encoding proteoglycans are associated with the risk of anterior cruciate ligament ruptures. Br J Sports Med 2014;48:1640-6. [PMID: 24552666 DOI: 10.1136/bjsports-2013-093201] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]

Abstract

BACKGROUND

Genetic variants within genes involved in fibrillogenesis have previously been implicated in anterior cruciate ligament (ACL) injury susceptibility. Proteoglycans also have important functions in fibrillogenesis and maintaining the structural integrity of ligaments. Genes encoding proteoglycans are plausible candidates to be investigated for associations with ACL injury susceptibility; polymorphisms within genes encoding the proteoglycans aggrecan (ACAN), biglycan (BGN), decorin (DCN), fibromodulin (FMOD) and lumican (LUM) were examined.

METHODS

A case-control genetic association study was conducted. 227 participants with surgically diagnosed ACL ruptures (ACL group) and 234 controls without any history of ACL injury were genotyped for 10 polymorphisms in 5 proteoglycan genes. Inferred haplotypes were constructed for specific regions.

RESULTS

The G allele of ACAN rs1516797 was significantly under-represented in the controls (p=0.024; OR=0.72; 95% CI 0.55 to 0.96) compared with the ACL group. For DCN rs516115, the GG genotype was significantly over-represented in female controls (p=0.015; OR=9.231; 95%CI 1.16 to 73.01) compared with the ACL group and the AA genotype was significantly under-represented in controls (p=0.013; OR=0.33; 95% CI 0.14 to 0.78) compared with the female non-contact ACL injury subgroup. Haplotype analyses implicated regions overlapping ACAN (rs2351491 C>T-rs1042631 T>C-rs1516797 T>G), BGN (rs1126499 C>T-rs1042103 G>A) and LUM-DCN (rs2268578 T>C-rs13312816 A>T-rs516115 A>G) in ACL injury susceptibility.

CONCLUSIONS

These independent associations and haplotype analyses suggest that regions within ACAN, BGN, DCN and a region spanning LUM-DCN are associated with ACL injury susceptibility. Taking into account the functions of these genes, it is reasonable to propose that genetic sequence variability within the genes encoding proteoglycans may potentially modulate the ligament fibril properties.

Collapse

Yin J, Tang W, Shao A, Wang L, Wang X, Ding G, Liu C, Chen Y, Chen S, Gu H. Caspase8 rs1035142 G>T polymorphism was associated with an increased risk of esophageal cancer in a Chinese population. Mol Biol Rep 2014;41:2037-43. [DOI: 10.1007/s11033-014-3052-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2013] [Accepted: 01/04/2014] [Indexed: 11/29/2022]

Dai G, Guo Z, Yang X, Yu B, Li L. Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: evidence from 40,762 cases and 50,380 controls. Mol Biol Rep 2013;40:4065-73. [PMID: 23292077 DOI: 10.1007/s11033-012-2484-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2012] [Accepted: 12/21/2012] [Indexed: 01/15/2023]

Universal nucleic acid sequence-based amplification for simultaneous amplification of messengerRNAs and microRNAs. Anal Chim Acta 2012;754:1-7. [PMID: 23140948 DOI: 10.1016/j.aca.2012.09.045] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2012] [Revised: 09/24/2012] [Accepted: 09/26/2012] [Indexed: 11/22/2022]

Lavender NA, Rogers EN, Yeyeodu S, Rudd J, Hu T, Zhang J, Brock GN, Kimbro KS, Moore JH, Hein DW, Kidd LCR. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. BMC Med Genomics 2012;5:11. [PMID: 22546513 PMCID: PMC3355002 DOI: 10.1186/1755-8794-5-11] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2011] [Accepted: 04/30/2012] [Indexed: 01/26/2023] Open

Abstract

Background

Molecular and epidemiological evidence demonstrate that altered gene expression and single nucleotide polymorphisms in the apoptotic pathway are linked to many cancers. Yet, few studies emphasize the interaction of variant apoptotic genes and their joint modifying effects on prostate cancer (PCA) outcomes. An exhaustive assessment of all the possible two-, three- and four-way gene-gene interactions is computationally burdensome. This statistical conundrum stems from the prohibitive amount of data needed to account for multiple hypothesis testing.

Methods

To address this issue, we systematically prioritized and evaluated individual effects and complex interactions among 172 apoptotic SNPs in relation to PCA risk and aggressive disease (i.e., Gleason score ≥ 7 and tumor stages III/IV). Single and joint modifying effects on PCA outcomes among European-American men were analyzed using statistical epistasis networks coupled with multi-factor dimensionality reduction (SEN-guided MDR). The case-control study design included 1,175 incident PCA cases and 1,111 controls from the prostate, lung, colo-rectal, and ovarian (PLCO) cancer screening trial. Moreover, a subset analysis of PCA cases consisted of 688 aggressive and 488 non-aggressive PCA cases. SNP profiles were obtained using the NCI Cancer Genetic Markers of Susceptibility (CGEMS) data portal. Main effects were assessed using logistic regression (LR) models. Prior to modeling interactions, SEN was used to pre-process our genetic data. SEN used network science to reduce our analysis from > 36 million to < 13,000 SNP interactions. Interactions were visualized, evaluated, and validated using entropy-based MDR. All parametric and non-parametric models were adjusted for age, family history of PCA, and multiple hypothesis testing.

Results

Following LR modeling, eleven and thirteen sequence variants were associated with PCA risk and aggressive disease, respectively. However, none of these markers remained significant after we adjusted for multiple comparisons. Nevertheless, we detected a modest synergistic interaction between AKT3 rs2125230-PRKCQ rs571715 and disease aggressiveness using SEN-guided MDR (p = 0.011).

Conclusions

In summary, entropy-based SEN-guided MDR facilitated the logical prioritization and evaluation of apoptotic SNPs in relation to aggressive PCA. The suggestive interaction between AKT3-PRKCQ and aggressive PCA requires further validation using independent observational studies.

Collapse

Guarrera S, Ricceri F, Polidoro S, Sacerdote C, Allione A, Rosa F, Voglino F, Critelli R, Russo A, Vineis P, Matullo G. Association between total number of deaths, diabetes mellitus, incident cancers, and haplotypes in chromosomal region 8q24 in a prospective study. Am J Epidemiol 2012;175:479-87. [PMID: 22350583 DOI: 10.1093/aje/kwr430] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open

Abstract

The 8q24 region is a gene desert, although chromosomal aberrations and somatic amplification involving this region, including translocations involving the protooncogene c-MYC, have been frequently reported in people with cancer. To investigate the role of variants in 8q24 region, the authors analyzed data from a prospective study (n = 10,372 participants who were followed for 11 years) in which a large number of health events (>1,500) occurred (1993-1998). They genotyped all subjects for 5 candidate single nucleotide polymorphisms (rs672888, rs1447295, rs9642880, rs16901979, and rs6983267) that were identified in previous genome-wide scans. Although significant associations with individual single nucleotide polymorphisms were small in magnitude, the authors observed higher increases in the risks of different types of cancer with specific haplotypes, particularly when subjects were homozygous for the haplotype: for breast cancer and homozygotes for haplotype CAGCT, hazard ratio = 3.40, 95% confidence interval: 1.24, 9.21; for prostate cancer and grouped rare haplotypes, hazard ratio = 7.43, 95% confidence interval: 3.00, 18.37; and for brain cancer and homozygotes for haplotype CGGCT, hazard ratio = 13.48, 95% confidence interval: 3.00, 59.53. Significant associations were also observed between haplotypes and deaths from cardiovascular diseases and cerebrovascular diseases; the most stable association was between homozygotes for haplotypes CGTCG and CAGCT and total deaths in men (hazard ratio = 3.5, 95% confidence interval: 1.8, 6.9, and hazard ratio = 2.8, 95% confidence interval: 1.3, 6.4, respectively). In conclusion, the authors have observed a strong pleiotropic effect of the 8q24 region in a large prospective study. This observation can shed light on the mechanisms underlying reported associations between 8q24 variants and disparate chronic diseases.

Collapse

Abnet CC, Wang Z, Song X, Hu N, Zhou FY, Freedman ND, Li XM, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Liao LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Chung CC, Wang C, Wheeler W, Yeager M, Yuenger J, Hutchinson A, Jacobs KB, Giffen CA, Burdett L, Fraumeni JF, Tucker MA, Chow WH, Zhao XK, Li JM, Li AL, Sun LD, Wei W, Li JL, Zhang P, Li HL, Cui WY, Wang WP, Liu ZC, Yang X, Fu WJ, Cui JL, Lin HL, Zhu WL, Liu M, Chen X, Chen J, Guo L, Han JJ, Zhou SL, Huang J, Wu Y, Yuan C, Huang J, Ji AF, Kul JW, Fan ZM, Wang JP, Zhang DY, Zhang LQ, Zhang W, Chen YF, Ren JL, Li XM, Dong JC, Xing GL, Guo ZG, Yang JX, Mao YM, Yuan Y, Guo ET, Zhang W, Hou ZC, Liu J, Li Y, Tang S, Chang J, Peng XQ, Han M, Yin WL, Liu YL, Hu YL, Liu Y, Yang LQ, Zhu FG, Yang XF, Feng XS, Wang Z, Li Y, Gao SG, Liu HL, Yuan L, Jin Y, Zhang YR, Sheyhidin I, Li F, Chen BP, Ren SW, Liu B, Li D, Zhang GF, Yue WB, Feng CW, Qige Q, Zhao JT, Yang WJ, Lei GY, Chen LQ, Li EM, Xu LY, Wu ZY, Bao ZQ, Chen JL, Li XC, Zhuang X, Zhou YF, Zuo XB, Dong ZM, Wang LW, Fan XP, Wang J, Zhou Q, Ma GS, Zhang QX, Liu H, Jian XY, Lian SY, Wang JS, Chang FB, Lu CD, Miao JJ, Chen ZG, Wang R, Guo M, Fan ZL, Tao P, Liu TJ, Wei JC, Kong QP, Fan L, Wang XZ, Gao FS, Wang TY, Xie D, Wang L, Chen SQ, Yang WC, Hong JY, Wang L, Qiu SL, Goldstein AM, Yuan ZQ, Chanock SJ, Zhang XJ, Taylor PR, Wang LD. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet 2012;21:2132-41. [PMID: 22323360 DOI: 10.1093/hmg/dds029] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open

Brisbin AG, Asmann YW, Song H, Tsai YY, Aakre JA, Yang P, Jenkins RB, Pharoah P, Schumacher F, Conti DV, Duggan DJ, Jenkins M, Hopper J, Gallinger S, Newcomb P, Casey G, Sellers TA, Fridley BL. Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. BMC MEDICAL GENETICS 2011;12:156. [PMID: 22142333 PMCID: PMC3267702 DOI: 10.1186/1471-2350-12-156] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/14/2011] [Accepted: 12/05/2011] [Indexed: 12/20/2022]

Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MWR, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A. Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev 2011;21:176-81. [PMID: 22056502 DOI: 10.1158/1055-9965.epi-11-0845] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

Familial pancreatic cancer. Cancers (Basel) 2010;2:1861-83. [PMID: 24281205 PMCID: PMC3840451 DOI: 10.3390/cancers2041861] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2010] [Revised: 11/03/2010] [Accepted: 11/04/2010] [Indexed: 12/11/2022] Open